In 1993, interferon beta-1b made history as the first drug to ever be approved for multiple sclerosis (MS). It also happens to be the year that Nancy Davis founded Race to Erase MS, an organization dedicated to funding cutting-edge, aggressive, and promising research in pursuit of a cure. To date, the organization has raised over $50 million for multiple sclerosis research.
